1. Home
  2. VNDA vs ORN Comparison

VNDA vs ORN Comparison

Compare VNDA & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • ORN
  • Stock Information
  • Founded
  • VNDA N/A
  • ORN 1994
  • Country
  • VNDA United States
  • ORN United States
  • Employees
  • VNDA N/A
  • ORN N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • VNDA Health Care
  • ORN Industrials
  • Exchange
  • VNDA Nasdaq
  • ORN Nasdaq
  • Market Cap
  • VNDA 362.6M
  • ORN 282.2M
  • IPO Year
  • VNDA 2006
  • ORN 2007
  • Fundamental
  • Price
  • VNDA $6.07
  • ORN $11.11
  • Analyst Decision
  • VNDA Buy
  • ORN Strong Buy
  • Analyst Count
  • VNDA 1
  • ORN 2
  • Target Price
  • VNDA $11.00
  • ORN $13.25
  • AVG Volume (30 Days)
  • VNDA 955.3K
  • ORN 766.2K
  • Earning Date
  • VNDA 07-29-2024
  • ORN 07-24-2024
  • Dividend Yield
  • VNDA N/A
  • ORN N/A
  • EPS Growth
  • VNDA N/A
  • ORN N/A
  • EPS
  • VNDA N/A
  • ORN N/A
  • Revenue
  • VNDA $177,604,000.00
  • ORN $713,276,000.00
  • Revenue This Year
  • VNDA $2.98
  • ORN $21.94
  • Revenue Next Year
  • VNDA $19.49
  • ORN $11.35
  • P/E Ratio
  • VNDA N/A
  • ORN N/A
  • Revenue Growth
  • VNDA N/A
  • ORN N/A
  • 52 Week Low
  • VNDA $3.30
  • ORN $2.91
  • 52 Week High
  • VNDA $6.75
  • ORN $11.61
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 57.74
  • ORN 66.77
  • Support Level
  • VNDA $5.75
  • ORN $8.18
  • Resistance Level
  • VNDA $5.39
  • ORN $8.69
  • Average True Range (ATR)
  • VNDA 0.27
  • ORN 0.56
  • MACD
  • VNDA 0.05
  • ORN 0.28
  • Stochastic Oscillator
  • VNDA 78.99
  • ORN 85.47

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: